Corcept Therapeutics (CORT) PT Raised to $131 at Piper Sandler Post-ROSELLA
Tweet Send to a Friend
Piper Sandler analyst David Amsellem raised the price target on Corcept Therapeutics (NASDAQ: CORT) to $131.00 (from $128.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
